NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

News orgs that let pharma make claims before releasing data

Posted By


This may be a trend. And if so, it’s a troubling one.

On, we’ve just posted a review of a Wall Street Journal story that we characterize as
“Another story that lets a drug company get away with making superiority claims without releasing data.”

Many news orgs let the makers of Provenge get away with this just a few days ago.

Stock manipulation anyone?

Is it going to kill anyone to wait until the data is actually released when independent expert opinion can be sought?

We don’t like this practice one bit.

Read how the the European Court of Justice views journalism that it equates with advertising.

You might also like


Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Comments are closed.